Fucosylated hybrid-type N-glycans on the secreted human epidermal growth factor receptor from swainsonine-treated A431 cells

Arch Biochem Biophys. 2000 Feb 1;374(1):42-51. doi: 10.1006/abbi.1999.1660.

Abstract

N-Glycans linked to the human secreted form of epidermal growth factor receptor were isolated from A431 cells after swainsonine treatment. Analysis of the oligosaccharides by (1)H NMR spectroscopy and mass spectrometry shows the presence of oligomannose- and (alpha2-3)-sialylated hybrid-type glycans. The major hybrid-type oligosaccharide chains are fucosylated at the Asn-bound GlcNAc residue. Smaller amounts of the hybrid-type structures are also fucosylated at peripheral GlcNAc residues, constituting the sialyl-Le(x) antigen. No complex-type glycans are found, suggesting the absence of alpha-mannosidase III. An assay for alpha-mannosidase III on the A431 cells in the absence and presence of 6 microM swainsonine shows that Man(5)GlcNAc(2) is not converted into Man(3)GlcNAc(2), thereby confirming that these cells do not contain alpha-mannosidase III activity.

MeSH terms

  • Amidohydrolases / metabolism
  • Carbohydrate Sequence
  • Chromatography, Agarose
  • Chromatography, Ion Exchange
  • Enzyme Inhibitors / pharmacology*
  • ErbB Receptors / metabolism*
  • Fucose / metabolism*
  • Glycosylation
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Molecular Sequence Data
  • Oligosaccharides / analysis
  • Oligosaccharides / isolation & purification
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
  • Polysaccharides / analysis
  • Polysaccharides / metabolism*
  • Swainsonine / pharmacology*
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Enzyme Inhibitors
  • Oligosaccharides
  • Polysaccharides
  • Fucose
  • ErbB Receptors
  • Amidohydrolases
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
  • Swainsonine